For more information, visit patientsaspartners.org.

For more information, visit DPHARMconference.com.

For more information, visit IO360summit.com. 

Valerie Bowling, Executive Director of the Conference Forum, discusses what attendees can expect at the 8th annual Patients as Partners EU conference, including keynotes, key topics, and the wide breadth of pharma companies present.  For more information about the upcoming event, full agenda and speakers, visit https://patientsaspartnerseu.com/

For more information, visit IO360summit.com.

As new drugs in development have poorer solubility and bioavailability, there is a need for novel solubility enhancing polymers to improve drug loading and improve patient adherence. In this podcast, Nick DiFranco explains some of the shortcomings of traditional solubility enhancers as well as key considerations for novel technologies. Nick also presents an overview of Lubrizol’s Apinovex™ polymers for oral solubility enhancement and Apisolex™ polymers for injectable solubility enhancement.  For more information about Lubrizol Life Science, visit Lubrizol.com.  For more information about the PODD Conference, please visit PODDConference.com.

For more information, visit DPHARMconference.com. 

For more information, visit DPHARMconference.com.

Summary: In this podcast, Terri Conneran tells the story of how her cancer diagnosis and a search for relevant biomarkers turned into KRAS Kickers, a cancer research advocate community.   For more information on PharmaTalk Radio podcasts, visit theconferenceforum.org. 

For more information, visit theconferenceforum.org. 

About the episode:  It's estimated that only 20% of health outcomes are due to clinical care, with the remaining 80% as a result of social determinants of health. Medicine development leaders must understand the broader context of patient lives in order to create therapies with real-world efficacy.  In this podcast, Noël Theodosiou tells us how she's working with life science companies, to understand and contextualize the real world that patients live in to create therapeutics that fit in the environment to deliver actual impact. Noël argues that taking an approach that combines biology, psychology and sociology provides companies with decision-making capabilities that connects good business practices with life science's social contracts with patients.   About the Speaker:  Noël Theodosiou is principal, founder and CEO of Luminous, which empowers organizations in the life sciences with insights, strategies, and capabilities that lead to better outcomes for patients, business, and society. Using proven methods such as behavioral science, culture and discourse analysis, and cutting-edge methodologies such as biosemiotics, we identify and address the myriad factors that influence health outcomes. www.luminouseffect.com.   For more information on PharmaTalkRadio podcasts, visit theconferenceforum.org.